Liu DY - Search Results

1

Relationship between icotinib hydrochloride exposure and clinical outcome in Chinese patients with advanced non-small cell lung cancer.

Ni J, Liu DY, Hu B, Li C, Jiang J, Wang HP, Zhang L. Ni J, et al. Among authors: liu dy. Cancer. 2015 Sep 1;121 Suppl 17:3146-56. doi: 10.1002/cncr.29568. Cancer. 2015. PMID: 26331821 Free article. Clinical Trial.

2

Quantitative determination of olmesartan in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.

Liu D, Hu P, Matsushima N, Li X, Li L, Jiang J. Liu D, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Sep 1;856(1-2):190-7. doi: 10.1016/j.jchromb.2007.05.049. Epub 2007 Jun 16. J Chromatogr B Analyt Technol Biomed Life Sci. 2007. PMID: 17602900

3

Pharmacokinetics and pharmacodynamics of vildagliptin in healthy Chinese volunteers.

Hu P, Yin Q, Deckert F, Jiang J, Liu D, Kjems L, Dole WP, He YL. Hu P, et al. J Clin Pharmacol. 2009 Jan;49(1):39-49. doi: 10.1177/0091270008325152. Epub 2008 Oct 1. J Clin Pharmacol. 2009. PMID: 18832295 Clinical Trial.

4

Quantitative determination of atorvastatin and para-hydroxy atorvastatin in human plasma by LC-MS-MS.

Liu D, Jiang J, Zhou H, Hu P. Liu D, et al. J Chromatogr Sci. 2008 Nov-Dec;46(10):862-6. doi: 10.1093/chromsci/46.10.862. J Chromatogr Sci. 2008. PMID: 19007492

5

Pharmacokinetic and safety profile of olmesartan medoxomil in healthy Chinese subjects after single and multiple administrations.

Jiang J, Liu D, Hu P. Jiang J, et al. Pharmazie. 2009 May;64(5):323-6. Pharmazie. 2009. PMID: 19530443 Clinical Trial.

6

Quantitative determination of icotinib in human plasma and urine using liquid chromatography coupled to tandem mass spectrometry.

Liu D, Jiang J, Hu P, Tan F, Wang Y. Liu D, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Nov 15;877(30):3781-6. doi: 10.1016/j.jchromb.2009.08.055. Epub 2009 Sep 24. J Chromatogr B Analyt Technol Biomed Life Sci. 2009. PMID: 19833564

7

Simultaneous quantitative determination of olmesartan and hydrochlorothiazide in human plasma and urine by liquid chromatography coupled to tandem mass spectrometry.

Liu D, Jiang J, Wang P, Feng S, Hu P. Liu D, et al. J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Mar 15;878(9-10):743-8. doi: 10.1016/j.jchromb.2010.01.009. Epub 2010 Jan 18. J Chromatogr B Analyt Technol Biomed Life Sci. 2010. PMID: 20153270

8

Phase I study of icotinib hydrochloride (BPI-2009H), an oral EGFR tyrosine kinase inhibitor, in patients with advanced NSCLC and other solid tumors.

Zhao Q, Shentu J, Xu N, Zhou J, Yang G, Yao Y, Tan F, Liu D, Wang Y, Zhou J. Zhao Q, et al. Lung Cancer. 2011 Aug;73(2):195-202. doi: 10.1016/j.lungcan.2010.11.007. Epub 2010 Dec 8. Lung Cancer. 2011. PMID: 21144613 Clinical Trial.

9

Metabolite characterization of a novel anti-cancer agent, icotinib, in humans through liquid chromatography/quadrupole time-of-flight tandem mass spectrometry.

Liu D, Jiang J, Zhang L, Tan F, Wang Y, Hu P. Liu D, et al. Rapid Commun Mass Spectrom. 2011 Aug 15;25(15):2131-40. doi: 10.1002/rcm.5061. Rapid Commun Mass Spectrom. 2011. PMID: 21732454

10

Effect of the CYP2C19 genotype on the pharmacokinetics of icotinib in healthy male volunteers.

Ruan CJ, Liu DY, Jiang J, Hu P. Ruan CJ, et al. Among authors: liu dy. Eur J Clin Pharmacol. 2012 Dec;68(12):1677-80. doi: 10.1007/s00228-012-1288-4. Epub 2012 May 15. Eur J Clin Pharmacol. 2012. PMID: 22585284

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

800 results

Search Page

Filters